https://www.selleckchem.com/pr....oducts/zilurgisertib
tandard of care as an adjunct to postoperative analgesia for patients who undergo outpatient ARCR. LEVEL OF EVIDENCE Level III, retrospective, comparative therapeutic trial. BACKGROUND Several studies in the Arab region have recognized the rate of nosocomial infections caused by Pseudomonas aeruginosa which produce β-lactamase and identified their emergence and prevalence in the region. This article seeks to review molecular studies on these β-lactamase producing Pseudomonas aeruginosa during the period 2010 to 2018 in se
Like
Comment
Share
